Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Viemed Healthcare, Inc.NASDAQ: VMD

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue rises 10.1% from a year ago

Deferred revenue stood at $7.48M at the end of Q1 FY2026, up 10.1% from a year earlier and down 0.5% from the prior quarter. Over 3 fiscal years it compounded at +17.6% a year.

Context

  • Deferred revenue amounted to 3.8% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +10.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.48M-0.5% QoQ
Last fiscal yearDec 2025
$7.52M+12.3% YoY
Year agoMar 2025
$6.8M+10.1% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+10.1%——
1 year+12.3%——
3-year CAGR+17.6%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
7.52M USD
Year-over-year change
+12.3%
4-year CAGR
+19.0%

Deferred Revenue vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's Mar 2026 deferred revenue of $7.48M is the 4th highest of the 11 companies compared; the peer median is $267K.
  • Its year-over-year change of +10.1% is the 3rd highest of 7, against a peer median of -3.3%.
  • Deferred revenue amounts to 3.8% of total assets for VMD, versus a peer median of 0.2%.
VMD Competitors Peer median
Deferred Revenue for VMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
QTRXQuanterix CorporationMar 2026$15.19M +66.9%+33.8%4.1%
OMOutset Medical, Inc.Mar 2026$12.64M -4.2%+16.8%5.1%
MASS908 Devices Inc.Mar 2026$9.47M -2.4%+5.9%5.1%
VMDViemed Healthcare, Inc.Mar 2026$7.48M +10.1%+17.6%3.8%
INGNInogen, Inc.Mar 2026$5.09M -20.6%-14.7%1.8%
NNOXNano-X Imaging Ltd.Dec 2025$534K +281.4%+43.2%0.3%
SGHTSight Sciences, Inc.Mar 2026$0 ——0.0%
SENSSenseonics Holdings, Inc.Mar 2026$0 ——0.0%
ELMDElectromed, Inc.Mar 2026$0 ——0.0%
CVRXCVRx, Inc.Mar 2026$0 ——0.0%
SNWVSANUWAVE Health, Inc.Mar 2026$0 -100.0%+86.3%0.0%
Peer median (excluding VMD) $267K-3.3%+25.3%0.2%

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents28.41M16.91M12.84M17.54M13.5M
Short-term Investments00000
Net Receivables14.72M15.41M18.45M24.91M25.59M
Inventory2.46M3.57M4.63M4.32M5.05M
Other Current Assets03.85M2.45M6.11M4.36M
Total Current Assets47.31M39.74M38.37M52.88M48.49M
Property, Plant & Equipment (Net)62.85M68.44M76.85M79.16M82.36M
Goodwill0029.77M32.99M58.94M
Intangible Assets00567K848K1.29M
Long-term Investments2.16M4.16M3.9M2.79M2.79M
Tax Assets4.79M3.12M4.56M8.4M5.29M
Other Non-current Assets862K1.59M887K015.79M
Total Non-current Assets70.65M77.3M116.53M124.19M166.45M
Total Assets117.96M117.04M154.9M177.07M214.94M
Account Payables5.25M4.9M7.41M9.34M12.33M
Short-term Debt1.48M01.07M409K1.09M
Tax Payables002.15M3.88M0
Deferred Revenue3.75M4.62M6.21M6.69M7.52M
Other Current Liabilities2.34M3.19M6.52M5.1M6.3M
Total Current Liabilities17.81M18.86M32.12M37.33M41.06M
Long-term Debt4.31M06M3.59M11.29M
Deferred Tax Liabilities000015.79M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities757K889K558K846K922K
Total Non-current Liabilities5.33M1.09M8.88M6.44M30.37M
Total Liabilities23.14M19.95M41M43.77M71.42M
Common Stock14.01M15.12M18.7M23.37M16.91M
Retained Earnings73.34M69.85M79.5M89.69M102.89M
Accumulated OCI(278K)0000
Other Stockholders Equity00000
Minority Interest0001.91M1.98M
Total Equity94.82M97.09M113.9M133.3M143.52M
Total Debt6.52M694K10.32M6.87M15.95M
Net Debt(21.89M)(16.22M)(2.52M)(10.67M)2.45M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.